Norges Bank’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Norges Bank’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-303,591	Closed	-$6.12M	–	2335
2021 Q3	$6.12M	Buy	+303,591	New	+$8.38M	﹤0.01%	1896

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Norges Bank's DRNA Position: Q4 2021 in Review

Norges Bank sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 303,591 shares — an estimated $6.12M sold.

Norges Bank first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $6.12M in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Norges Bank reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Norges Bank sold 303,591 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $6.12M.
Norges Bank first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
Norges Bank's Dicerna Pharmaceuticals, Inc. position peaked at $6.12M in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Norges Bank's 13F filing for Q4 2021, filed 10 Feb 2022.